• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Notice sent to Jaipur hospital for conducting trials of Patanjali coronil drug on COVID-19 patients

By PTI
|

Jaipur, June 26: Rajasthan's Health Department has served a notice to NIMS hospital here seeking an explanation on conducting trials of Patanjali Ayurved's drug Coronil on coronavirus patients, an official said on Friday.

Notice sent to Jaipur hospital for conducting trials of Patanjali coronil drug on COVID-19 patients

"We served notice to the hospital on Wednesday evening seeking explanation in three days. The hospital did not inform the state government nor sought permission," Chief Medical and Health Officer, Jaipur, Dr Narottam Sharma said. He said the reply from National Institute of Medical Science (NIMS), Jaipur is awaited.

Coronavirus causes mild disease in most children, fatalities rare: Lancet study

The launch of the drug by yoga guru Ramdev on Tuesday triggered a debate after which the Ayush Ministry sought all information on its trial and put a ban on advertising it as a drug to cure coronavirus. The Rajasthan government has clarified that the drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH.

    Delhi CM cautions Covid patients, says oxygen drops suddenly in some cases | Oneindia News

    State Health Minister Raghu Sharma had said on Wednesday that strict action would be taken against the seller as per the rules in case of sale of any drug as a medicine to treat the coronavirus infection. At the Coronil launch, the company had claimed that its medicine can cure the contagious disease within seven days.

    It said Coronil, taken along with another product developed by it, had shown a 100 per cent success rate in clinical trials on infected patients, except those on life support. Ramdev said the medicines were developed by Patanjali Research Center, Haridwar in association with privately-owned National Institute of Medical Science (NIMS), Jaipur.

    The Uttarakhand government will serve a notice to Patanjali Ayurved for launching a drug claiming to be a cure for COVID-19 when it had only applied for a licence to manufacture an immunity booster against cough and fever. Apart from the notice from the Uttarakhand government, the Haridwar-based firm could also face litigation in Bihar. A complaint has been filed against it in a Muzaffarpur court over its claim.

    A complainant approached the court seeking the registration of an FIR against Ramdev and company chairman Acharya Balkrishna, alleging that they put at risk the lives of lakhs of people by claiming to have developed a COVID-19 cure. Chief Judicial Magistrate Mukesh Kumar posted the matter for hearing on June 30.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more